International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.
Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, Guerreiro M, Gwer S, Zuberi SM, Wilmshurst JM, Yozawitz E, Pressler R, Hirsch E, Wiebe S, Cross HJ, Perucca E, Moshé SL, Tinuper P, Auvin S.
Epilepsia. 2022 Jun;63(6):1398-1442. doi: 10.1111/epi.17241. Epub 2022 May 3.
The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.
Orsini A, Valetto A, Bertini V, Esposito M, Carli N, Minassian BA, Bonuccelli A, Peroni D, Michelucci R, Striano P.
Seizure. 2019 Oct;71:247-257. doi: 10.1016/j.seizure.2019.08.012. Epub 2019 Aug 23.
The glucose transporter type 1 (Glut1) syndromes.
Koch H, Weber YG.
Epilepsy Behav. 2019 Feb;91:90-93. doi: 10.1016/j.yebeh.2018.06.010. Epub 2018 Jul 31.
International consensus on diagnosis and management of Dravet syndrome.
Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, Wilmshurst J, Sullivan J.
Epilepsia. 2022 Jul;63(7):1761-1777. doi: 10.1111/epi.17274. Epub 2022 May 12.
Epilepsy.
Valman HB.
Br Med J (Clin Res Ed). 1982 Apr 24;284(6324):1247-50. doi: 10.1136/bmj.284.6324.1247.
Epilepsy with myoclonic absences: A case series.
Videira G, Raimundo R, Chorão R.
Seizure. 2023 Mar;106:162-163. doi: 10.1016/j.seizure.2023.02.017. Epub 2023 Feb 24.
Epilepsy with myoclonic absences.
Bureau M, Tassinari CA.
Brain Dev. 2005 Apr;27(3):178-84. doi: 10.1016/j.braindev.2004.01.008.
Epilepsy with myoclonic absences.
Genton P, Bureau M.
CNS Drugs. 2006;20(11):911-6. doi: 10.2165/00023210-200620110-00004.
Myoclonic-astatic epilepsy.
Doose H.
Epilepsy Res Suppl. 1992;6:163-8.
Transition issues for benign epilepsy with centrotemporal spikes, nonlesional focal epilepsy in otherwise normal children, childhood absence epilepsy, and juvenile myoclonic epilepsy.
Camfield CS, Berg A, Stephani U, Wirrell EC.
Epilepsia. 2014 Aug;55 Suppl 3:16-20. doi: 10.1111/epi.12706.
